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4 These authors contributed equally to this manuscrThe presence of heterotrimeric G-proteins at epithelial tight junctions suggests that these cellular
junctions are regulated by so far unknown G-protein coupled receptors. We identify here an inter-
action between the human somatostatin receptor 3 (hSSTR3) and the multiple PDZ protein MUPP1.
MUPP1 is a tight junction scaffold protein in epithelial cells, and as a result of the interaction with
MUPP1 the hSSTR3 is targeted to tight junctions. Interaction with MUPP1 enables the receptor to
regulate transepithelial permeability in a pertussis toxin sensitive manner, suggesting that hSSTR3
can activate G-proteins locally at tight junctions.
Structured summary:
MINT-6800756, MINT-6800770: MUPP1 (uniprotkb:O75970) and hSSTR3 (uniprotkb:P32745) colocalize
(MI:0403) by ﬂuorescence microscopy (MI:0416)
MINT-6800587:hSSTR3 (uniprotkb:P32745) physically interacts (MI:0218) with MUPP1 (uniprotkb:
O55164) by pull down (MI:0096)
MINT-6800562:hSSTR3 (uniprotkb:P32745) physically interacts (MI:0218) with MUPP1 (uniprotkb:
O75970) by two hybrid (MI:0018)
MINT-6800622:hSSTR3 (uniprotkb:P32745) physically interacts (MI:0218) with PIST (uniprotkb: Q9HD26),
Hsp70 (uniprotkb:P08107), Maguk p55 (uniprotkb: Q8N3R9), MAGI3 (uniprotkb:Q5TCQ9), ZO-2 (uni-
protkb:Q9UDY2), ZO-1 (uniprotkb:Q07157) and MUPP1 (uniprotkb:O55164) by pull down (MI:0096)
MINT-6800607, MINT-6801122:hSSTR3 (uniprotkb:P32745) physically interacts (MI:0218) with MUPP1
(uniprotkb:O75970) by anti bait coimmunoprecipitation (MI:0006)
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ipt.Tight junctions (TJs) form the permeability barrier in epithelial
tissues. A complex assembly of cell surface molecules such as
occludin and claudins with intracellular anchoring proteins includ-
ing the PDZ domain proteins zonula occuldens 1 (ZO-1), ZO-2 and
multiple PDZ domain protein 1 (MUPP1) determines tightness and
permeability of TJs [1]. Various signaling molecules regulate for-
mation and permeability of TJs, including heterotrimeric G-pro-
teins [2,3]. Gai2, Gao and Ga12 subunits are localized at TJs or
can interact with the TJ scaffold ZO-1 [2–4]. However, so far it
has remained unclear which G-protein coupled receptors (GPCRs)lsevier B.V. All rights reserved.
50 C.W. Liew et al. / FEBS Letters 583 (2009) 49–54might be available to exert any inﬂuence on TJ function via these
G-proteins.
Here, we provide evidence for the regulation of transepithelial
resistance by the G-protein coupled human somatostatin (SST)
receptor 3 (hSSTR3). All SSTR subtypes (SSTR1-5) preferentially cou-
ple to inhibitory, pertussis toxin (Ptx) sensitive G-proteins and exhi-
bit common intracellular coupling patterns [5,6]. We show that
hSSTR3 interacts with the tight junction protein MUPP1
(multi-PDZ domain protein 1) via a PDZ domain of MUPP1. This
interaction allows for incorporation of receptors into TJs in a PDZ-
dependent manner, and enables hSSTR3 to regulate transepithelial
conductance.
2. Materials and methods
2.1. Materials
Rabbit anti-MUPP1 and guinea pig anti-hSSTR3 antisera were
generated using GST-fusion proteins of MUPP1-PDZ10 and the
hSSTR3 C-terminus, respectively, by custom immunization at Biog-
enes GmbH, Berlin, Germany, and afﬁnity-puriﬁed using immobi-
lized antigens. Rabbit anti-SSTR3 has been described [7]. Anti-T7
was from Novagen (Madison, WI); anti-b-catenin from BD Trans-
duction Labs (Heidelberg, Germany).
cDNA coding for hSSTR3 was ampliﬁed from human genomic
DNA and cloned into a modiﬁed pcDNA3 (Invitrogen, Leek, TheFig. 1. Species speciﬁc interaction of the hSSTR3 C-terminus with MUPP1. (A) Domain
Original positive ‘‘ﬁsh” clones derived from library screening (indicated by upper four lin
with different bait plasmids to score for growth on plates lacking histidine (quadruple
several colonies after retransformation was seen as a positive (+) interaction, whereas t
differences between individual MUPP1 constructs containing the region coding for PDZ10
proteins were incubated with immobilized synthetic peptides derived from the C-termin
precipitates were analyzed by immunoblotting with MUPP1 antibody. (C) Coprecipitati
afﬁnity-puriﬁed, immobilized anti-MUPP, anti-shank (directed against the N-terminus of
(In) and precipitates (P) were analyzed by Western blotting (WB) with the antibodies in
larger than the predicted size of 43 kDa, possibly due to glycosylation. In addition large
multimerized forms of the receptor. (D). HEK or MCF7 cellular lysates were subjected to
peptides. Puriﬁed protein complexes were analyzed by SDS–PAGE; bands were identiﬁeNetherlands) providing an N-terminal T7-epitope tag (pcDNA3-
NT7) in frame with the hSSTR3 coding sequence. Fusion constructs
with mouse SSTR5 were generated by PCR and also cloned into
pcDNA3-NT7.
2.2. Two-hybrid screening
A pGBKT7 (Clontech) derived bait plasmid containing a cDNA
fragment coding for the C-terminal, intracellular domain of the
human SSTR3 (Accession No. M96738; amino acids 317–419)
was screened against a pretransformed human brain cDNA library
in pACT-2 (Clontech). Plasmids from positive candidates were
isolated and sequenced.
2.3. Precipitation assays
Synthetic peptides corresponding to the C-termini of rat (KAS-
TLSHL) and human (KSSTMRISYL) SSTR3 as well as the rat guany-
late kinase associated protein/synapse associated protein
associated protein (IYIPEAQTRL) were obtained from Genemed
Synthesis Inc., San Francisco, CA. Peptides were immobilized on
NHS-Sepharose (Amersham Pharmarcia Biotech) and used for pull-
down assays as described [8]. Puriﬁed proteins were analyzed by
SDS–PAGE, tryptic digestion and mass spectroscopy [8].
For immunoprecipitation, puriﬁed anti-MUPP1 antibody,
anti-hSSTR3 or antibodies directed against a GST-fusion of thestructure of MUPP1, and result of two-hybrid screen with the hSSTR3 C-terminus.
es), as well as clones generated for mapping the interaction, were combined in yeast
dropout medium, lacking Trp, Leu, His and adenine). In each case robust growth of
he lack of colonies was evaluated as a negative result (); nd, not determined. No
were observed. hSSTR3DCT lacks the C-terminal 8 residues. (B) Solubilized rat brain
i of GKAP (negative control, con), the rat (rS3) and the human SSTR3 (hS3). Input and
on of hSSTR3 and MUPP1 from MCF7 cells. Cleared lysates were precipitated with
human shank1; used here as negative control) and anti-hSSTR3, as indicated. Input
dicated. hSSTR3 migrates at a molecular weight of approximately 50 kDA, slightly
r bands are observed in the MUPP1 IP which may represent higher glycosylated or
afﬁnity chromatography using immobilized hSSTR3 (hS3) or GKAP (con) C-terminal
d by mass spectrometry.
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antibody) were bound to protein A/G sepharose (Santa Cruz Bio-
technology, Santa Cruz, CA). After washing, antibodies were cross-
linked to the beads with dimethylpimelimidate. MCF7 cells were
lyzed in RIPA buffer, and immunoprecipitations were performed
from cleared lysates using in each case 50 ll of antibody matrix.
For subsequent detection of the hSSTR3, samples were denatured
in sample buffer at 60 C for 10 min, to avoid aggregation.
2.4. Tissue culture
MCF7 cells (ATCC) were cultured in DMEM + 10% FCS, 10 mM
HEPES, pH 7.4 and 10 lg/ml insulin. Keratinocytes were isolated
from human foreskin and cultured in KGM supplemented with
0.07 mM Ca2+ (Cascade Biologics). For differentiation, they were
cultured for 48 h in high Ca2+ (1.8 mM) medium with additives
(0.2 lg/ml hydrocortisone, 5 lg/ml insulin and 50 lg/ml ascorbic
acid). Madin-Darby canine kidney-II (MDCK-II) and HEK-293 cells
were cultured in DMEM + 10% FCS; in order to obtain polarized
epithelia, MDCK-II cells were grown on Transwell ﬁlters (Costar,
Corning, NY). TER was measured using Millicell-ERS (Millipore,
Eschborn, Germany). Statistical analysis was performed using Stu-
dent’s t-test.
2.5. Immunocytochemistry
Cells growing on Transwell ﬁlters were ﬁxed with 4% parafor-
maldehyde in PBS and permeabilized with 0.1% Triton X-100 in
PBS for 15 min at room temperature. After blocking (5% horse ser-Fig. 2. The hSSTR3 C-terminus mediates targeting to cellular junctions in MDCK-II cells
anti-T7, green ﬂuorescence; left) with the endogenous MUPP1 protein (afﬁnity-puriﬁed a
indicates colocalization. x and y Sections as well as x and z section obtained from the sam
transmembrane region; PDZ-L, PDZ ligand motif. Black, hSSTR3; grey, mSSTR5; numbers
of membrane preparations indicates equal T7-SSTR levels for cell lines expressing the trun
4). The molecular weights of the two receptor variants are indicated. (D) MDCK-II cells e
receptor, left) and anti-b-catenin antibodies (middle). The merged picture is shown on
keratinocytes. (F) Colocalization of both proteins at cellular junctions using afﬁnity-purum in PBS) cells were incubated with anti-T7 antibody (1:5000 in
blocking solution) or puriﬁed polyclonal anti-MUPP PDZ10 anti-
body (1:100) overnight at 4 C, followed by 1 h of incubation with
Cy2-conjugated anti-mouse and Cy3-conjugated anti-rabbit sec-
ondary antibody (1:500). Immunostaining was visualized by con-
focal microscopy (Leica). Keratinocytes were grown on coverslips
to conﬂuency, differentiated with high Ca2+-medium and incu-
bated with primary antibodies (rabbit anti-MUPP 1:100, guinea
pig anti-SSTR3 1:20) followed by secondary antibody incubation
(Cy3-anti-rabbit 1:400, AlexaFluor488-anti-guinea pig 1:1500).
3. Results
Using the C-terminus of the hSSTR3 as bait in a two-hybrid
screen, we identiﬁed the PDZ domain protein MUPP1 (Accession
No NM_003829; 16 independent clones; Fig. 1A) as potential inter-
acting partner. Mapping experiments showed that interaction is
mediated by the C-terminal PDZ ligand motif of the receptor, and
PDZ domain 10 of MUPP1. Surprisingly, the rat SSTR3 which carries
a slightly modiﬁed PDZ ligand motif at its C-terminus, does not
interact with any of the PDZ domain proteins. The species-speciﬁc
nature of the interaction was conﬁrmed by peptide pulldown
experiments from rat brain. MUPP1 was readily detected in lysate
and in precipitate obtained with human SSTR3 C-terminal peptide.
Using the rat peptide for the pulldown, a faint band was detected
only after overexposure of the blot (Fig. 1B). By homology model-
ling [9] we identiﬁed a tyrosine at the 1 position of the human
peptide ligand (histidine in the rat), as well as two additional
residues present in the human SSTR3 C-terminus which determine. (A and B) Costaining of T7-hSSTR variants expressed in MDCK-II cells (labelled by
nti-MUPP1, red ﬂuorescence, middle). Yellow staining in the merged images (right)
e area are shown. The chimeric nature of the SSTR-constructs used is indicated; TM,
refer to amino acid positions in the sequence. Bars, 10 lm. (C) Western blot analysis
cated (lane 1) and the full-length fusion receptor (three different cell lines, lanes 2–
xpressing the full-length fusion receptor were stained using anti-T7 (detecting the
the right. (E) Detection of hSSTR3 (left) and MUPP1 (right) in primary cultured
iﬁed anti-hSSTR3 (left) and anti-MUPP1 (middle); Bars, 5 lm.
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(Supplementary Fig. S1). A comparison with other SSTR3 sequences
shows that most vertebrate species actually carry a tyrosine at the
-1 position (Table S1). Inability to bind PDZ10 of MUPP1 is there-
fore a peculiarity of the rodent SSTR3, which however precludes
the use of mouse and rat model systems for functional studies.
Interaction of hSSTR3 with MUPP1 was demonstrated in a na-
tive cellular system by coimmunoprecipitation of the endogenous
hSSTR3 and MUPP1 proteins from lysates of human MCF-7 cells
(Fig. 1C). We detected several MUPP1-speciﬁc bands in these cells
by Western blotting, consistent with the existence of several splice
variants (C.W.L., unpublished observations). Previous experience
has shown that SSTRs are expressed at low levels, making it
difﬁcult to detect receptor speciﬁc bands without prior enrichment
[8]. Nevertheless, when precipitating MUPP1, we observed
hSSTR3-speciﬁc bands in the precipitate at approximately 50 kDa
(calculated: 46 kDa), as well as a smear of larger bands ranging
from 70–90 kDa which presumably reﬂect differentially glycosyl-
ated receptors. In the reverse experiment, MUPP1 was detected
in the precipitate when hSSTR3 was precipitated. As only a faint
MUPP1-speciﬁc band could be observed, we assume that only a
fraction of total MUPP1 is associated with the hSSTR3.
Several attempts were made to deﬁne how the interaction with
MUPP1 affects hSSTR3 function. In coexpression experiments in
CHO cells, coupling of the hSSTR3 to its typical downstream effec-Fig. 3. hSSTR3 regulates TER in MDCK-II cells in a biphasic manner. (A) Filters carrying
indicated were subjected to Ca-switch; junctions were allowed to reform in the absence
***Signiﬁcantly different from control conditions, P < 0.001 as determined by Student
expressing SSTR5S3C (C–D) were subjected to Ca-switch, and TER recovery in the absence
D were identical with the exception that different time points were included in D. The bi
15 h after Ca-switch. Note that non-transfected cells do not respond to SST-treatment. **P
was preincubated overnight at 400 ng/ml. Note that Ptx blocks the early reduction as w
cells, values represent the mean ± S.E.M. determined from three independent experimen
independently generated cell lines.tor, the G-protein gated inwardly rectifying potassium channel
(GIRK; see Ref. [5]) was not affected by the interaction with
MUPP1. In particular the activation and deactivation kinetics of
SST-14 induced currents were not altered in these experiments
(Supplementary Fig. S2).
Next, we analyzed whether MUPP1 might integrate hSSTR3 into
a larger protein complex; taking advantage of the high afﬁnity of
the hSSTR3 C-terminus to MUPP1, we puriﬁed MUPP1-associated
proteins from human cell lines (Fig. 1D). Mass spectrometric anal-
ysis indicated the presence of scaffold proteins ZO-1, ZO-2, MAGI-
3, MAGUKp55/Pals, which are known components of epithelial
tight junctions. Indeed, MUPP1 has been described as a scaffold
protein in tight junctions in MDCK cells [10]. Interestingly, Ptx-
sensitive G-proteins have also been localized at tight junctions
[3,4]. However, so far no GPCR has been identiﬁed which could
activate these G-proteins locally at the junctions. Therefore, we
analyzed a possible role of hSSTR3 in TJs of epithelial cells. Unfor-
tunately, hSSTR3 overexpression causes apoptosis in many cell
lines [11] including the MDCK-derived lines tested (data not
shown). However, we could generate MDCK-II derived cell lines
expressing fusion constructs of the N-terminal and transmem-
brane part of mouse SSTR5 (which does not cause apoptosis) and
the C-terminus of hSSTR3. Analysis of transfected cells showed that
the C-terminal PDZ ligand motif of the SSTR3 mediates targeting of
recombinant receptors to tight junctions, as the SSTR5-derivedconﬂuent layers of MDCK-II cells or MDCK-II cells expressing the SSTR-constructs
or presence of agonist (1 lM SST-28). TER was measured 15 hours after Ca-switch.
’s t-test. (B–D) Time course. Non-transfected MDCK-II cells (B) or MDCK-II cells
or presence of 1 lM SST-28 was recorded at the times indicated. Conditions in C and
phasic nature of the reponse to SST is evident; the effect is reversed between 10 and
< 0.001; *P < 0.05. (E) Sensitivity of SST induced changes to pertussis toxin (Ptx). Ptx
ell as the the late increase in TER induced by SST-28. For non-transfected MDCK-II
ts. For transfected cells, values represent the mean ± S.E.M. determined from three
C.W. Liew et al. / FEBS Letters 583 (2009) 49–54 53fusion receptor carrying the SSTR3 C-terminus (SSTR5S3C) colocal-
ized with MUPP1 at the junctions, whereas a fusion receptor lack-
ing the last 8 residues (SSTR5S3-DC) was distributed diffusely
throughout the cell surface (Fig. 2A and B). The expression level
of the receptor was not affected by the truncation, as determined
by Western blotting of membrane preparations derived from
transfected cells (Fig. 2C). Costaining with an antibody against
b-catenin revealed that the chimeric receptor is indeed localized
apical relative to adherens junctions, further conﬁrming targeting
to tight junctions (Fig. 2D).
Recently, hSSTR3 was reported to be expressed in skin [12];
therefore we analyzed the distribution of the endogenous hSSTR3
in primary cultured keratinocytes which were differentiated by
high Ca2+ concentrations; similar to MUPP1, the protein was found
here also at cellular junctions, and colocalization of both proteins
was observed (Fig. 2E and F).
To analyze the functional role of the receptor at TJs, we em-
ployed the so-called calcium switch paradigm; here Ca2+ is brieﬂy
removed to disrupt cellular junctions, leading to a complete loss of
transepithelial resistance. Reformation of tight junctions was then
induced by the addition of Ca2+, and the development of TER was
followed in the presence or absence of the SSTR agonist SST28.
At 15 h after the switch, cells expressing the SSTR5S3C construct
(which binds the MUPP1 PDZ domain) exhibited strongly increased
TER when agonist was present during recovery (Fig. 3A). Non-
transfected cells or those expressing a construct which lacks the
C-terminal PDZ motif (SSTR5S3CDC) on the other hand did not re-
spond to SST-treatment. Analysis of TER at earlier times after Ca-
switching revealed that the response to SST in MDCK cells is bipha-
sic, as TER values actually declined in the SSTR expressing cell line
relative to control cells (non-treated, or treated but not transfec-
ted) during the ﬁrst 10 h after the Ca-switch (Fig. 3B–E), but in-
creased strongly at later time points (15–23 h). After that, TER
gradually decreased again. Importantly, both the initial decrease
and the subsequent increase in TER values induced by SST28 were
sensitive to pertussis toxin treatment (Fig. 3E). This indicates that
targeting of hSSTR3 to tight junctions via its C-terminal interaction
enables localized control of TJ permeability via heterotrimeric G-
protein dependent signalling.4. Discussion
Our data indicate a strong and speciﬁc interaction between the
human somatostatin receptor subtype 3 and PDZ domain 10 of
MUPP1. We have previously established that the C-termini of
somatostatin receptors may interact with PDZ domain proteins
[8]; in fact, all SSTR subtypes contain potential PDZ ligand motifs.
PDZ-type interactions have previously been shown not to affect
the ‘‘normal” signal transduction pathways, but rather to couple
a given receptor to additional, new downstream signalling events
[13]. This is also evident here, as the interaction with MUPP1 did
not have any inﬂuence on coupling of hSSTR3 to the GIRK1/2, a
well established effector of SSTRs [5]. In epithelial cells, targeting
of the hSSTR3 to tight junctions depends on its PDZ ligand motif,
implying MUPP1 to be responsible for the junctional localization.
Receptor lacking the PDZ ligand is diffusely distributed throughout
cells, whereas only the receptor with the ligand motif is found
colocalized with MUPP1 at tight junctions. Currently, our data sug-
gest that due to its interaction with a MUPP1-based complex at TJs,
the receptor can control the formation and permeability of epithe-
lial barriers, as indicated by TER measurements in transfected
MDCK-II cells. Further work will show whether other MUPP1-asso-
ciated GPCRs such as serotonin 5-HT2 receptors or the melatonin 1
receptor [14–16] might contribute to the regulation of TJs. Interest-
ingly, interaction of the 5-HT2C receptor with MUPP1 is inhibitedby the agonist-induced phosphorylation of the receptor within its
C-terminal PDZ ligand motif [17], suggesting that targeting of
receptors to cellular junctions may be dynamically regulated upon
receptor activation. We did not analyze this aspect with respect to
the hSSTR3/MUPP1 interaction. However, our previous analysis of
the rat SSTR3 indicated that agonist-dependent phosphorylation
sites in the C-terminal domain are not located within the putative
PDZ ligand motif, but more proximal to the plasma membrane
[18]. Most of these sites are conserved from rat to human SSTR3.
Subsequent to phosphorylation, receptors are internalized [18]; it
will be important to analyze whether the interaction with MUPP1
is maintained during endocytosis, and whether such a redistribu-
tion of MUPP1 contributes to the reduction of TER observed in
the early phase of agonist treatment.
Taken together, the expression of the SSTR3 in epithelial tissues,
such as prostate [19] and kidney [20] and skin (see above), and the
ability of the receptor to regulate tight junctions indicate that SST
can affect permeability and biogenesis of these biological barriers.Acknowledgements
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